Johnson & Johnson Revises Sales Guidance Higher Yet Again
publication date: Jul 16, 2019
Image Shown: Johnson & Johnson revised its expected sales growth rate for 2019 upwards, however, pressures on its operating margin forced management to keep adjusted EPS forecasts the same. Image Source: Johnson & Johnson – IR Presentation.
Consumer packaged goods and healthcare giant Johnson & Johnson, a holding in both our simulated Best Ideas Newsletter and Dividend Growth Newsletter portfolios, reported second-quarter 2019 earnings July 16 that received mixed reviews from the market. Shares of JNJ initially sold off before recovering later in the trading day.
This page is available to subscribers only. To gain access to members only content (including this research piece), click here to subscribe. With a subscription, you'll have access to all of our premium commentary, equity reports, dividend reports and Best Ideas Newsletter and Dividend Growth Newsletter, as well as receive discounts on all of our modeling tools and products. Financial advisers and institutional investors have even more to choose from!